The diagnostic power of single (CRP, cholesterol, BMI, ALT, and miRNA-34) to diagnose NAFLD was evaluated using area under ROC and presented in Table 2. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.